Awardee OrganizationHEALTH RESEARCH INC, NEW YORK STATE DOH
Description
Abstract Text
DESCRIPTION (provided by applicant): The current West Nile virus (WNV) epidemic/epizootic in the United States is exhibiting unprecedented avian mortality, equine disease, involvement of many vertebrate and vector species, and non-vector transmission. Perennial outbreaks in the Northeast point toward the local establishment of natural foci rather than reintroduction by migrating birds. However, we know very little with regard to endemic/enzootic WNV transmission dynamics or if non-vector transmission manifests itself under field conditions. Host behavior likely plays a role in determining local transmission patterns particularly for directly transmitted diseases. The crow's complex social relationships lend themselves to indolent transmission studies. Our specific hypothesis is that non-vector transmission, crow movement and secondary transmission cycles play an important role in the local transmission, amplification and persistence of WNV. We have an exclusive opportunity to test our hypothesis by enlisting a well-studied and marked American crow (Conus brachyrhynchos) population. First, behavioral risk factors, e.g., contact with sick birds, infectious feces and carcasses, hypothesized to play a role in the risk of WNV transmission among crows will be collated in an ambidirectional epidemiology study to determine if non-vector transmission is manifested in the field. Second, we will document the movement of crow families with marked individuals and known family members by sightings, radio-tagging, and nighttime observations using infrared cameras and determine whether mosquito infection and human risk is enhanced on home territories as a result of crow movement. And third, we will determine the involvement of non-Culex mosquitoes to test the notion that when abundant these species play a role in secondary transmission cycles. This is an important piece of detective work involving a Category B agent that will have valuable implications for public health policies relating to mosquito control, arboviral encephalitis prevention and risks associated with non-vector transmission.
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
153695809
UEI
WJ37AD42G8A5
Project Start Date
01-April-2005
Project End Date
31-March-2007
Budget Start Date
01-April-2005
Budget End Date
31-March-2006
Project Funding Information for 2005
Total Funding
$236,770
Direct Costs
$200,000
Indirect Costs
$36,770
Year
Funding IC
FY Total Cost by IC
2005
National Institute of Allergy and Infectious Diseases
$236,770
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R21AI064305-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21AI064305-01
Patents
No Patents information available for 1R21AI064305-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21AI064305-01
Clinical Studies
No Clinical Studies information available for 1R21AI064305-01
News and More
Related News Releases
No news release information available for 1R21AI064305-01
History
No Historical information available for 1R21AI064305-01
Similar Projects
No Similar Projects information available for 1R21AI064305-01